Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Bolt Biotherapeutics
640 Galveston Drive
Redwood City, CA 94063
Phone: 650-665-9295
http://boltbio.com/

Bolt Biotherapeutics is a private biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of cancer therapeutics. These systemically-administered, tumor-targeted Boltbody™ therapeutics unleash the immune system to induce anti-tumor immunity. The company is led by a team with extensive oncology drug discovery and development experience. Bolt was founded by Dr. Ed Engleman, professor of pathology and medicine, Stanford Medicine, and its platform is based on technology exclusively licensed from Stanford University.

Key Contact
NameTitleE-Mail
Edgar G. Engleman, MDFounder & Director


Funding Events
DateAmountTypeInvestors
02/05/19$54,000,000Series B Nan Fung
Novo Holdings
Pivotal bioVenture Partners  
Vivo Capital
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.